» Articles » PMID: 22301017

[State of Acute Phase Markers and Oxidative Stress in Patients with Kidney Stones in the Urinary Tract]

Overview
Journal Actas Urol Esp
Specialty Urology
Date 2012 Feb 4
PMID 22301017
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This present study has aimed to assess the state of acute phase markers and oxidative stress in patients with kidney stones.

Material And Methods: A prospective study was carried out on 100 patients with kidney stones and 25 healthy controls. Albumin, ß2 microglobulin, Gamma-glutamyl transpepsidase, Lactate dehydrogenase, Tumor necrosis factor alpha, Interleukin 1 and Interleukin-6 were evaluated as acute phase markers and lipid peroxidation products, Superoxide dismutase and Glutathione peroxidase levels acted as oxidative stress markers.

Results: An increase in renal cell damage markers as expressed by the ß2 microglobulin (p=0.04), albumin (p=0.004), Lactate dehydrogenase (p=0.001) and Gamma glutamyl transpepsidasa (p=0.01) was observed in the patient group. There was a direct correlation between levels of ß2 microglobulin and stone size (r=0.3, p=0.03). The association between stone size and cytokine activation was observed to be stronger in patients with staghorn calculi. In these patients, Tumor necrosis factor alpha (p=0.011), Interleukin 1 (p=0.004) and Interleukin 6 (p=0.004) were significantly higher. Patients with stones in the urinary tract showed data of significantly higher oxidative stress, expressed as an increase in levels of lipid peroxidation products (p=0.03) and a decrease in the antioxidant activity of Superoxide dismutase (p=0.03) and Glutathione peroxidase (p=0.002).

Conclusions: Patients undergoing urolithiasis showed an elevation of acute phase markers, associated with oxidative stress as expressed by an increase in lipid peroxidation products and a decrease in the antioxidant enzyme activity.

Citing Articles

Relationship Between Urolithiasis and Fatty Liver Disease: Findings in Computed Tomography.

Lubinus Badillo F, Cala O, Vera Campos S, Villarreal Ibanez E Tomography. 2020; 6(1):1-4.

PMID: 32280744 PMC: 7138524. DOI: 10.18383/j.tom.2020.00020.


Effects of short-term atorvastatin use in patients with calcium stones: A randomized placebo-controlled clinical trial.

Taheri F, Taheri M, Basiri A, Khoshdel A, Samadian F, Tavasoli S Investig Clin Urol. 2019; 60(6):472-479.

PMID: 31692870 PMC: 6821987. DOI: 10.4111/icu.2019.60.6.472.


Vitamin D and calcium kidney stones: a review and a proposal.

Tavasoli S, Taheri M Int Urol Nephrol. 2018; 51(1):101-111.

PMID: 30136085 DOI: 10.1007/s11255-018-1965-z.


Urinary calculi and risk of cancer: a nationwide population-based study.

Shih C, Chen Y, Ou S, Yang W, Chen T, Tarng D Medicine (Baltimore). 2014; 93(29):e342.

PMID: 25546684 PMC: 4602593. DOI: 10.1097/MD.0000000000000342.


Increased risk of bone fracture among patients with urinary calculi: a nationwide longitudinal population-based study.

Ou S, Chen Y, Shih C, Tarng D Osteoporos Int. 2014; 26(4):1261-9.

PMID: 25524022 DOI: 10.1007/s00198-014-2998-5.